48.20 +0.27 (0.56%)
Pre-Market: 5:49AM EST
Previous Close | 48.27 |
Open | 48.57 |
Bid | 47.81 x 1100 |
Ask | 48.99 x 1200 |
Day's Range | 47.55 - 48.59 |
52 Week Range | 33.36 - 55.49 |
Volume | 9,430,082 |
Avg. Volume | 6,891,425 |
Market Cap | 41.414B |
Beta (5Y Monthly) | 0.47 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.80 |
Earnings Date | Mar 31, 2021 - Apr 05, 2021 |
Forward Dividend & Yield | 1.87 (3.87%) |
Ex-Dividend Date | Feb 18, 2021 |
1y Target Est | 46.61 |
Letters on Oracle’s cloud-computing business, Vanguard, Felix Zulauf, short-term interest rates, Warren Buffett’s buybacks, and market predictions
3 Pharmacies & Drugstore Stocks to Watch Amid COVID-19 Resurgence
Shares of Walgreens Boots Alliance Inc. gained 0.3% in trading on Thursday, the day after the pharmacy giant said it will begin selling over-the-counter COVID-19 tests developed by the Laboratory Corporation of America Holdings . Labcorp's stock was down 1.8%. The at-home PCR test kits will be sold at pharmacy counters in an estimated 6,000 Walgreens stores in the U.S. sometime this spring, allowing people to buy a kit, self-administer a nasal swab, and mail the sample back to Labcorp via FedEx. People do not need a prescription to purchase the test kit. A Walgreens spokesperson said in an email that it is not disclosing the price of the test at this time. Over the past 12 months, Walgreen's stock has gained 4.1% and shares of Labcorp are up 29.9%. The S&P 500 is up 21.7%.